FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Epizon Ltd.
 2. Date of Event Requiring Statement (Month/Day/Year)
11/02/2015		 3. Issuer Name and Ticker or Trading Symbol
Rennova Health, Inc. [RNVA]
(Last)
(First)
(Middle)
SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NASSAU, C5 000000		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,884,334 (1)
D
 
Series B Convertible Preferred Stock 1,000 (2)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Epizon Ltd.
SUITE 104A, SAFFREY SQUARE, BANK LANE
PO BOX N-9306
NASSAU, C5 000000		     X    
The Shanovan Trust
SUITE 104A, SAFFREY SQUARE, BANK LANE
PO BOX N-9306
NASSAU, BAHAMAS, C5 000000		     X    

Signatures

Epizon Ltd., By: /s/ P. Wilhelm F. Toothe, trustee of The Shanoven Trust 01/11/2016
**Signature of Reporting Person Date
The Shanoven Trust, By: /s/ P. Wilhelm F. Toothe, trustee 01/11/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Received in connection with the merger transaction with Medytox Solutions, Inc. ("Medytox"), in exchange for 4,600,000 shares of Medytox common stock, based upon an exchange ratio of 0.4096377408003329 per share.
(2) Received in connection with the merger transaction with Medytox in exchange for 1,000 shares of Medytox Series B Preferred Stock.
 
Remarks:
Exhibit List - Exhibit 99 - Joint Filer Information

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.